GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $154,000 | -27.7% | 3,653 | -25.2% | 0.04% | -20.4% |
| Q1 2022 | $213,000 | -4.5% | 4,884 | -3.2% | 0.05% | -7.5% |
| Q4 2021 | $223,000 | +50.7% | 5,046 | +30.5% | 0.05% | +35.9% |
| Q3 2021 | $148,000 | -9.2% | 3,868 | -5.7% | 0.04% | -9.3% |
| Q2 2021 | $163,000 | +30.4% | 4,101 | +16.8% | 0.04% | +19.4% |
| Q1 2021 | $125,000 | -7.4% | 3,512 | -4.0% | 0.04% | -16.3% |
| Q4 2020 | $135,000 | -8.8% | 3,660 | -6.9% | 0.04% | +48.3% |
| Q3 2020 | $148,000 | -22.9% | 3,930 | -16.7% | 0.03% | -60.3% |
| Q2 2020 | $192,000 | -8.1% | 4,716 | -14.4% | 0.07% | -27.7% |
| Q1 2020 | $209,000 | -11.4% | 5,509 | +9.7% | 0.10% | +6.3% |
| Q4 2019 | $236,000 | +2.6% | 5,021 | -7.0% | 0.10% | +20.3% |
| Q3 2019 | $230,000 | +4.1% | 5,399 | -2.4% | 0.08% | -10.2% |
| Q2 2019 | $221,000 | -16.9% | 5,531 | -13.2% | 0.09% | -20.7% |
| Q1 2019 | $266,000 | -22.4% | 6,374 | -28.9% | 0.11% | -34.3% |
| Q4 2018 | $343,000 | – | 8,959 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |